GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED

This adverse event was reported 13 times

These drugs are most commonly taken by patients reporting GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED:

# Drug Count
0 CISPLATIN 5
1 GEMCITABINE HYDROCHLORIDE 4
2 GEMCITABINE 2
3 PAZOPANIB 2
4 PAZOPANIB HYDROCHLORIDE 2
5 BENDAMUSTINE HYDROCHLORIDE 1
6 CARBOPLATIN 1
7 DOXORUBICIN HYDROCHLORIDE 1
8 IFOSFAMIDE 1
9 IFOSFAMIDE FOR INJECTION 1
See all common drugs associated with GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED

GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BENDAMUSTINE HYDROCHLORIDE 1 0.0001
1 PAZOPANIB HYDROCHLORIDE 2 0.0001
2 GEMCITABINE HYDROCHLORIDE 4 0.0001
3 CISPLATIN 5 0.0001
4 IFOSFAMIDE FOR INJECTION 1 0.0000
5 NIRAPARIB 1 0.0000
6 DOXORUBICIN HYDROCHLORIDE 1 0.0000
7 VENETOCLAX 1 0.0000
8 NIVOLUMAB 1 0.0000
9 PACLITAXEL 1 0.0000
See all drugs enriched for association with GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED

GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Platinum-based Drug [EPC] 6 0.0000
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
2 BCL-2 Inhibitor [EPC] 1 0.0000
3 Microtubule Inhibitor [EPC] 1 0.0000
4 Alkylating Drug [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 2 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
See all drug classes enriched for association with GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL INCREASED